Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K-M Chu

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Alimentary Pharmacology & Therapeutics|January 13, 2005
Evaluation of anti-Helicobacter pylori IgG2 antibody for the diagnosis of Helicobacter pylori infection in western and Chinese populationsZ Ren, T Borody, G Pang, et al.
World Journal of Surgery|March 1, 1997
Intrahepatic cholangiocarcinomaK M Chu, E C Lai, S Al-Hadeedi, et al.
Clinical Pharmacology and Therapeutics|December 2, 1998
Antiulcer drug prescribing in hospital successfully influenced by "immediate concurrent feedback"C R Kumana, T Y Ching, E Cheung, et al.
Complementary Therapies in Medicine|May 8, 2004
A survey of attitudes to Traditional Chinese Medicine in Hong Kong pharmacy studentsE K L Hon, K Lee, H M Tse, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2003
A rapid-release 50-mg tablet-based 13C-urea breath test for the diagnosis of Helicobacter pylori infectionW M Wong, S K Lam, K C Lai, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2003
Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users--a randomized trialK C Lai, S K Lam, K M Chu, et al.
Endoscopy|March 29, 2003
A prospective comparison of performance of biopsy forceps used in single passage with multiple bites during upper endoscopyK M Chu, S T Yuen, W M Wong, et al.
Journal of Clinical Pharmacology|September 21, 2001
Fosinopril: pharmacokinetics and pharmacodynamics in Chinese subjectsP Y Ding, K M Chu, O Y Hu, et al.
Alimentary Pharmacology & Therapeutics|January 21, 2006
Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infectionW M Wong, Q Gu, K-M Chu, et al.
Alimentary Pharmacology & Therapeutics|September 20, 2007
Clinical trial: levofloxacin-based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infectionY K Yee, T K Cheung, K-M Chu, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Alimentary Pharmacology & Therapeutics|January 13, 2005
Evaluation of anti-Helicobacter pylori IgG2 antibody for the diagnosis of Helicobacter pylori infection in western and Chinese populationsZ Ren, T Borody, G Pang, et al.
World Journal of Surgery|March 1, 1997
Intrahepatic cholangiocarcinomaK M Chu, E C Lai, S Al-Hadeedi, et al.
Clinical Pharmacology and Therapeutics|December 2, 1998
Antiulcer drug prescribing in hospital successfully influenced by "immediate concurrent feedback"C R Kumana, T Y Ching, E Cheung, et al.
Complementary Therapies in Medicine|May 8, 2004
A survey of attitudes to Traditional Chinese Medicine in Hong Kong pharmacy studentsE K L Hon, K Lee, H M Tse, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2003
A rapid-release 50-mg tablet-based 13C-urea breath test for the diagnosis of Helicobacter pylori infectionW M Wong, S K Lam, K C Lai, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2003
Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users--a randomized trialK C Lai, S K Lam, K M Chu, et al.
Endoscopy|March 29, 2003
A prospective comparison of performance of biopsy forceps used in single passage with multiple bites during upper endoscopyK M Chu, S T Yuen, W M Wong, et al.
Journal of Clinical Pharmacology|September 21, 2001
Fosinopril: pharmacokinetics and pharmacodynamics in Chinese subjectsP Y Ding, K M Chu, O Y Hu, et al.
Alimentary Pharmacology & Therapeutics|January 21, 2006
Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infectionW M Wong, Q Gu, K-M Chu, et al.
Alimentary Pharmacology & Therapeutics|September 20, 2007
Clinical trial: levofloxacin-based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infectionY K Yee, T K Cheung, K-M Chu, et al.
Pageof 11